Clinical Trial Update: A Study of ZL-1310 in Subjects With Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial update for ZL-1310 in patients with small cell lung cancer, and the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• ZL-1310

Snippet

Sponsor: Zai Lab (Shanghai) Co., Ltd. | Conditions: SCLC | Phase 1 | Status: RECRUITING